Gebel M - Search Results

1

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

Ten Cate H, Lensing AWA, Weitz JI, Middeldorp S, Beyer-Westendorf J, Kubitza D, Brighton T, Raskob GE, Mismetti P, Prandoni P, Gebel M, Prins MH. Ten Cate H, et al. Among authors: gebel m. Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15. Thromb Res. 2018. PMID: 30121419

2

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.

Davidson BL, Verheijen S, Lensing AW, Gebel M, Brighton TA, Lyons RM, Rehm J, Prins MH. Davidson BL, et al. Among authors: gebel m. JAMA Intern Med. 2014 Jun;174(6):947-53. doi: 10.1001/jamainternmed.2014.946. JAMA Intern Med. 2014. PMID: 24733305

3

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy.

Wells PS, Gebel M, Prins MH, Davidson BL, Lensing AW. Wells PS, et al. Among authors: gebel m. Thromb J. 2014 Nov 26;12:26. doi: 10.1186/1477-9560-12-26. eCollection 2014. Thromb J. 2014. PMID: 25698905 Free PMC article.

4

Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.

Kooistra HA, Gebel M, Sahin K, Lensing AW, Meijer K. Kooistra HA, et al. Among authors: gebel m. Thromb Haemost. 2015 Nov 25;114(6):1136-43. doi: 10.1160/TH14-12-1033. Epub 2015 Jul 30. Thromb Haemost. 2015. PMID: 26224199 Clinical Trial.

5

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Martinelli I, Lensing AW, Middeldorp S, Levi M, Beyer-Westendorf J, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Trajanovic M, Gebel M, Lam P, Wells PS, Prins MH. Martinelli I, et al. Among authors: gebel m. Blood. 2016 Mar 17;127(11):1417-25. doi: 10.1182/blood-2015-08-665927. Epub 2015 Dec 22. Blood. 2016. PMID: 26696010 Free PMC article.

6

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG. Ageno W, et al. Among authors: gebel m. Lancet Haematol. 2016 Jan;3(1):e12-21. doi: 10.1016/S2352-3026(15)00257-4. Epub 2015 Dec 8. Lancet Haematol. 2016. PMID: 26765643

7

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

Wells PS, Prins MH, Levitan B, Beyer-Westendorf J, Brighton TA, Bounameaux H, Cohen AT, Davidson BL, Prandoni P, Raskob GE, Yuan Z, Katz EG, Gebel M, Lensing AWA. Wells PS, et al. Among authors: gebel m. Chest. 2016 Nov;150(5):1059-1068. doi: 10.1016/j.chest.2016.05.023. Epub 2016 Jun 1. Chest. 2016. PMID: 27262225 Clinical Trial.

8

Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.

Turpie AGG, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Ageno W. Turpie AGG, et al. Among authors: gebel m. Thromb Res. 2017 Jul;155:23-27. doi: 10.1016/j.thromres.2017.04.001. Epub 2017 Apr 13. Thromb Res. 2017. PMID: 28477534 Clinical Trial.

9

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.

Prandoni P, Lensing AWA, Prins MH, Gebel M, Pap AF, Homering M, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Cohen AT, Davidson BL, van Bellen B, Verhamme P, Wells PS, Yuan Z, Levitan B, Weitz JI. Prandoni P, et al. Among authors: gebel m. Thromb Res. 2018 Aug;168:121-129. doi: 10.1016/j.thromres.2018.06.009. Epub 2018 Jul 10. Thromb Res. 2018. PMID: 30064683

10

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W. Klok FA, et al. Among authors: gebel m. Br J Haematol. 2018 Nov;183(3):457-465. doi: 10.1111/bjh.15533. Epub 2018 Aug 19. Br J Haematol. 2018. PMID: 30123981 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page